Cargando…
Case report: inability to achieve a therapeutic dose of tacrolimus in a pediatric allogeneic stem cell transplant patient after generic substitution
BACKGROUND: Tacrolimus is an immunosuppressive drug that is used to lower the activity of the patient’s immune system to prevent organ rejection. Unfortunately, there is limited data regarding the therapeutic equivalency of generic tacrolimus formulations especially in children. We report the case o...
Autores principales: | Madian, Ashraf G, Panigrahi, Arun, Perera, Minoli A, Pinto, Navin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287354/ https://www.ncbi.nlm.nih.gov/pubmed/25472557 http://dx.doi.org/10.1186/2050-6511-15-69 |
Ejemplares similares
-
A Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients
por: Alloway, R R, et al.
Publicado: (2012) -
Systematic conversion to generic tacrolimus in stable kidney transplant recipients
por: Rosenborg, Staffan, et al.
Publicado: (2014) -
Generic Substitution
por: Walley, T.
Publicado: (1993) -
Generic Substitution
por: Cheng, Tsung O
Publicado: (1993) -
Efficacy and safety of a switch from twice-daily tacrolimus to once-daily generic tacrolimus in stable liver transplant patients
por: Kim, Jong Man, et al.
Publicado: (2021)